Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia

Samuel B Anyona1,2, Qiuying Cheng3, Sharley A Wasena4,5

  • 1Department of Medical Biochemistry, School of Medicine, Maseno University, Maseno, 40105, Kenya. sanyona@maseno.ac.ke.

Nature Communications
|June 12, 2024
PubMed

Insights

Severe malarial anemia (SMA) in children involves impaired immune responses and cellular regulation. Transcriptome analysis reveals disrupted pathways, offering potential therapeutic targets for this life-threatening condition.

Area of Science:

  • Immunology
  • Genomics
  • Pediatric Infectious Diseases

Background:

  • Severe malarial anemia (SMA) is a major cause of childhood illness and death globally.
  • Understanding the molecular mechanisms of SMA is crucial for developing effective treatments.

Purpose of the Study:

  • To compare the whole blood host transcriptome of children with and without SMA.
  • To identify molecular pathways and cellular responses involved in SMA pathogenesis.

Main Methods:

  • Whole blood transcriptome analysis (RNA-Seq) in Kenyan children (3-48 months) with and without SMA.
  • Differential gene expression analysis, immune cell profiling, and pathway enrichment analyses.
  • Validation using targeted RNA-Seq in a Ugandan SMA cohort.

Main Results:

  • SMA is associated with 1403 up-regulated and 279 down-regulated transcripts.
  • Key findings include impaired inflammasome activation, cell death, innate immunity, and memory responses.
  • Disruptions in cellular homeostasis, ubiquitin-proteasome system, autophagy, heme metabolism, and hypoxia-inducible factor (HIF)-1/ROS signaling were observed.

Conclusions:

  • SMA involves complex molecular disruptions, including immature/improperly regulated immune responses and altered cellular homeostasis.
  • Hypoxia-related signaling pathways are central to SMA pathogenesis.
  • These findings highlight potential novel therapeutic targets for SMA.